5-(3-bromo-4-(dimethylamino)phenyl)-2,2-dimethyl-2,3,5,6-tetrahydrobenzo(a)phenanthridin-4(1H)-one,
Glutaminase C-IN-1,
311795-38-7,
CHEBI:60279,
5-[3-bromo-4-(dimethylamino)phenyl]-2,2-dimethyl-2,3,5,6-tetrahydrobenzo[a]phenanthridin-4(1H)-one,
Glutaminase Inhibitor Compound 968,
5-(3-bromo-4-(dimethylamino)phenyl)-2,2-dimethyl-2,3,5,6-tetrahydrobenzo[a]phenanthridin-4(1H)-one,
5-[3-bromo-4-(dimethylamino)phenyl]-2,2-dimethyl-1,3,5,6-tetrahydrobenzo[a]phenanthridin-4-one,
Compound 968,
AC1MJXN7,
MLS006011732,
SCHEMBL2635251,
CHEMBL2133369,
DTXSID90389215,
BCP18024,
EX-A2335,
Glutaminase C-IN-1; Compound 968,
QC-219,
AKOS000518068,
CS-4585,
MCULE-7842076917,
NCGC00263232-01,
NCGC00263232-02,
AK547730,
BAS 00323446,
HY-12682,
SMR003863855,
ST076764,
EU-0084810,
AG-690/36107028,
5-[3-Bromo-4-(dimethylamino)phenyl]-2,2-dimethyl-2,3,5,6-tetrahydrobenzo[a]phenanthridine-4(1H)-one,
5-[3-Bromo-4-(dimethylamino)phenyl]-2,3,5,6-tetrahydro-2,2-dimethylbenzo[a]phenanthridin-4(1H)-one,
5-[4-(dimethylamino)-3-bromophenyl]-2,2-dimethyl-1,2,3,5,6-pentahydrobenzo[a]p henanthridin-4-one,
Glutaminase C-IN-1 (968),
ZINC02067776,
CID3099980,